Cargando…
Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
YH4808 is a novel selective potassium-competitive acid blocker demonstrated to be safe and to have inhibitory effects against gastric acid secretion in previous studies. A randomized, open-label, multiple-dose, 3-treatment, 1-period, parallel design study was conducted to compare the Helicobacter py...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533165/ https://www.ncbi.nlm.nih.gov/pubmed/33062627 http://dx.doi.org/10.12793/tcp.2020.28.e16 |